Published in Hepatitis Weekly, March 26th, 2007
"We assessed Stat3 expression and DNA-binding as well as expression of its regulators protein...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.